A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

NCT03469011 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Lack of Accrual

Conditions

Papillary Thyroid Cancer

Interventions

DRUG: Imatinib Oral Tablet

Sponsor

AHS Cancer Control Alberta

Collaborators

[object Object]